The Copenhagen Triage Algorithm is non-inferior to a traditional triage algorithm: A cluster-randomized study

Rasmus Bo Hasselbalch, Mia Pries-Heje, Martin Schultz, Louis Lind Plesner, Lisbet Ravn, Morten Lind, Rasmus Greibe, Birgitte Nybo Jensen, Thomas Høi-Hansen, Nicholas Carlson, Christian Torp-Pedersen, Lars S Rasmussen, Kasper Iversen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

6 Citationer (Scopus)
72 Downloads (Pure)

Abstract

INTRODUCTION: Triage systems with limited room for clinical judgment are used by emergency departments (EDs) worldwide. The Copenhagen Triage Algorithm (CTA) is a simplified triage system with a clinical assessment.

METHODS: The trial was a non-inferiority, two-center cluster-randomized crossover study where CTA was compared to a local adaptation of Adaptive Process Triage (ADAPT). CTA involves initial categorization based on vital signs with a final modification based on clinical assessment by an ED nurse. We used 30-day mortality with a non-inferiority margin at 0.5%. Predictive performance was compared using Receiver Operator Characteristics.

RESULTS: We included 45,347 patient visits, 23,158 (51%) and 22,189 (49%) were triaged with CTA and ADAPT respectively with a 30-day mortality of 3.42% and 3.43% (P = 0.996) a difference of 0.01% (95% CI: -0.34 to 0.33), which met the non-inferiority criteria. Mortality at 48 hours was 0.62% vs. 0.71%, (P = 0.26) and 6.38% vs. 6.61%, (P = 0.32) at 90 days for CTA and ADAPT. CTA triaged at significantly lower urgency level (P<0.001) and was superior in predicting 30-day mortality, Area under the curve: 0.67 (95% CI 0.65-0.69) compared to 0.64 for ADAPT (95% CI 0.62-0.66) (P = 0.03). There were no significant differences in rate of admission to the intensive care unit, length of stay, waiting time nor rate of readmission within 30 or 90 days.

CONCLUSION: A novel triage system based on vital signs and a clinical assessment by an ED nurse was non-inferior to a traditional triage algorithm by short term mortality, and superior in predicting 30-day mortality.

TRIAL REGISTRATION: Clinicaltrials.gov NCT02698319.

OriginalsprogEngelsk
Artikelnummere0211769
TidsskriftPLoS ONE
Vol/bind14
Udgave nummer2
Antal sider13
ISSN1932-6203
DOI
StatusUdgivet - 2019

Citationsformater